For Emergency BLOOD requirement in any city in India, SMS to 5676775
"Blood < s p a c e > PIN code of your city < s p a c e > required blood group < s p a c e > your name"

Thursday, 6 September 2007

New Stocks in FnO Listing Gains

New 14 stocks have come into force in the FnO segment from today. See what listing gains have come in.


 closing rate closing rate high rate % change
symbol 29-Aug-07 30-Aug-07 6-Sep-07 from 30th till



10:55 hrs today's high
3IINFOTECH 136.80 137.60 156.40 13.66
APTECHT 297.85 286.65 341.70 19.20
BHUSANSTL 657.40 659.90 974.00 47.60
BIOCON 431.20 433.95 477.00 9.92
CMC 980.90 982.70 1185.00 20.59
HAVELLS 462.80 460.90 537.40 16.60
LAXMIMACH 2747.20 2756.45 3170.00 15.00
NIITTECH 430.45 281.45 362.00 28.62
NUCLEUS 341.55 335.65 385.50 14.85
SASKEN 311.40 319.80 394.80 23.45
TECHM 1219.15 1196.05 1331.30 11.31
TULIP 781.95 782.80 957.00 22.25
WELGUJ 225.70 233.00 258.20 10.82
YESBANK 166.70 168.00 193.45 15.15

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)
Miscellaneous Articles - Live Data - Charts - R E G U L A R - A R T I C L E S - Some Blogs - BSE Links - NSE Equity Links - NSE FnO Links - NSE Links - SEBI Links - Websites/Web-Links - Business Papers - Mutual Funds - Forums for Interaction
Disclaimer : Recommendations or suggestions given here are totally free. Care has been taken to give correct advice / information / recommendations / suggestions /tips. We take no guarantee that the mentioned analysis will work to your benefit. Since we are involved in the market, we take pleasure in giving the best for the benifit of all. We have interest in the market and may or may not have positions in some or all of the stocks that are mentioned. We do not have any clients as such. These views are purely personal. We do not take any responsibility in any profits or losses that any one incurs as a result of these views / suggestions / recommendations / advice / tip /etc. Please do your own due diligence before initiating any trades as a result of this information.

Followers